Right Ventricular Strain in Detecting Subclinical Right Ventricular Systolic Dysfunction in Psori⦠(NCT07046312) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Right Ventricular Strain in Detecting Subclinical Right Ventricular Systolic Dysfunction in Psoriatic Arthritis Patients: Relation to Serum Endostatin Level
Egypt60 participantsStarted 2025-07
Plain-language summary
The aim is to assess early right ventricular systolic dysfunction in psoriatic arthritis patients using RV strain echocardiography
Who can participate
Age range20 Years ā 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Psoriatic arthritis patients according to CASPAR criteria
* Psoriatic arthritis patients without overt cardiovascular symptoms
* Patients with age between 20 to 50 years of age
Exclusion Criteria:
* Other systemic autoimmune diseases
* Patients with a history of known valvular disease, atrial fibrillation or any other arrhythmia , heart failure, ischemic cardiomyopathy severe obstructive pulmonary diseases and metabolic syndrome.
* Patients with medical disorders as renal, congenital heart diseases, hematological disorders and cancer patients.
* Patients taking certain drugs that have been confirmed to be risk factors for PAH such as appetite suppressant intake drugs (aminorex, fenfluramine derivatives and benfluorex) and chemotherapeutic agents.
* Family history of myocardial infarction, cerebrovascular disease or sudden death before the age of 65y in females and 55 y in males.
What they're measuring
1
Detecting subclinical right ventricular systolic dysfunction in PsA patients